|
|
Bottom
|
|
|
(to view contract details, including Documents, click 'Display Expanded Data Set' button, bottom right) |
| ID | Subject | Agency | Vendor | Award Date | Completion Date | Current Value(Excludes Options not Exercised) | Max Value(Includes Options not Exercised) | Competitively Procured? |
|
UTH108630
|
FY23 BPO HEMOPHILIA FACTOR MEDICATION
|
744 - The University of Texas Health Science Center at Houston
|
CSL BEHRING LLC
|
09/07/2022
|
08/30/2023
|
$5,176,000
|
$5,176,000
|
No, non-emergency sole source procurement
|
| | | | | | | | | |
|
|
|
|
|
Top
|